Thrombophilia Market Report 2026
Download Free Sample Buy Now
Thrombophilia Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Thrombophilia Market Report 2026

Global Outlook – By Type (Factor V Leiden, Prothrombin 20210, Antiphospholipid Syndrome, Other Type), By Drugs (Heparin, Warfarin, Other Drugs), By Route Of Administration (Oral, Parenteral, Other Route Of Administration), By End-Users (Hospitals, Homecare, Specialty Centers, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Thrombophilia Market Overview

• Thrombophilia market size has reached to $18.18 billion in 2025

• Expected to grow to $26.5 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%

• Growth Driver: Surge In Thrombophilic Conditions Fuels Growth In The Thrombophilia Market

• Market Trend: Groundbreaking Technological Advances And Long-Acting Drugs On The Horizon

• North America was the largest region in 2025.

What Is Covered Under Thrombophilia Market?

Thrombophilia is a blood disorder that increases the risk of blood clotting in the veins and arteries. It can be caused by blood clotting in arteries and veins or by an inherited (genetic) or acquired disposition. It has the potential to cause a heart attack, stroke, kidney failure, and pulmonary embolism.

The main types of thrombophilia are factor V leiden, prothrombin 20210, antiphospholipid syndrome, and others. Factor V Leiden is a mutation in one of the blood-clotting factors. The drugs include Heparin, Warfarin, and others with a variety of administration routes, such as oral and parenteral. The end-users include hospitals, home health agencies, specialty centers, and others.

Thrombophilia Market Global Report 2026 Market Report bar graph

What Is The Thrombophilia Market Size and Share 2026?

The thrombophilia market size has grown strongly in recent years. It will grow from $18.18 billion in 2025 to $19.6 billion in 2026 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to rising prevalence of inherited blood disorders, limited awareness of thrombophilia, growth in hospital infrastructure, early adoption of anticoagulant therapies, increasing cardiovascular disease incidences.

What Is The Thrombophilia Market Growth Forecast?

The thrombophilia market size is expected to see strong growth in the next few years. It will grow to $26.5 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to expansion of genetic testing services, adoption of AI-based diagnostic tools, integration of telehealth platforms, growth in homecare anticoagulant management, increasing healthcare expenditure in emerging markets. Major trends in the forecast period include personalized anticoagulant therapy, increased genetic screening for thrombophilia, advanced diagnostic testing for blood clotting disorders, rise in awareness programs for blood disorders, integration of telemedicine in thrombophilia management.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Thrombophilia Market Segmentation

1) By Type: Factor V Leiden, Prothrombin 20210, Antiphospholipid Syndrome, Other Type

2) By Drugs: Heparin, Warfarin, Other Drugs

3) By Route Of Administration: Oral, Parenteral, Other Route Of Administration

4) By End-Users: Hospitals, Homecare, Specialty Centers, Other End Users

Subsegments:

1) By Factor V Leiden: Genetic Testing, Anticoagulant Therapy

2) By Prothrombin 20210: Genetic Testing, Anticoagulant Therapy

3) By Antiphospholipid Syndrome: Antiphospholipid Antibody Testing, Anticoagulant Therapy

4) By Other Types: Protein C Deficiency, Protein S Deficiency, Antithrombin III Deficiency

What Is The Driver Of The Thrombophilia Market?

The increasing prevalence of thrombophilic conditions is expected to propel the growth of the thrombophilia market in the coming years. Thrombophilic diseases, often known as thrombophilia, are a category of illnesses marked by an increased proclivity to develop blood clots (thrombosis). Thrombophilic conditions play an important role in the thrombophilia market, impacting diagnosis, treatment techniques, and current research. For instance, in July 2025, according to PubMed, a US-based publicly accessible online database of biomedical literature, reported that factor V Leiden and prothrombin G202110A mutations significantly raise the prevalence of stillbirth with a pooled OR of 2.35 (95% CI 1.74-3.17) and 2.62 (95% CI 1.79-3.84), respectively. This positive correlation did not change in the sensitivity analysis. Positive correlation was also found between antithrombin deficiency. Therefore, the increasing prevalence of thrombophilic conditions is driving the thrombophilia industry.

Key Players In The Global Thrombophilia Market

Major companies operating in the thrombophilia market are Pfizer Inc., F. Hoffmann-La Roche Limited, Fresenius Kabi AG, Hikma Pharmaceuticals PLC., Novartis AG, Shenzhen Hepalink Pharmaceutical Group Co. Limited, Teva Pharmaceutical Industries Limited, Sanofi SA, Boehringer Ingelheim GmbH, Instrumentation Laboratory SpA, Johnson & Johnson, Bristol-Myers Squibb, Roche, Abbott, C. H. Boehringer Sohn, Portola Pharmaceuticals, Daiichi Sankyo, Bayer Group, CSL Behring, Merck & Co Inc., Janssen Pharmaceuticals

Global Thrombophilia Market Trends and Insights

Major companies operating in the thrombophilia market are focusing on developing innovative technologies, such as long-acting fusion protein therapies for coagulation factor replacement, to meet the rising demand for improved treatment durability, fewer administrations, and enhanced patient compliance in bleeding disorders and thrombophilia-related conditions. Long-acting fusion protein therapies combine coagulation factors with carrier proteins or Fc fragments to extend half-life in the bloodstream, reduce dosing frequency compared to traditional factor replacements, and improve overall patient quality of life. For instance, in May 2023, researchers at the University of California, San Diego, developed a groundbreaking technology known as Eloctate that holds the potential to transform the treatment of hemophilia. This innovative approach utilizes a novel fusion protein that significantly enhances the stability and half-life of coagulation factors in the bloodstream. By combining this technology with existing therapies, the researchers aim to create long-acting drugs that require less frequent administration, thereby improving patient compliance and quality of life.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Thrombophilia Market?

In March 2025, Tempus AI, a US-based provider of artificial intelligence-driven precision medicine, oncology diagnostics, and data analytics platforms, acquired Ambry Genetics for an undisclosed amount. With this acquisition, Tempus AI aimed to expand its hereditary and rare disease testing capabilities, enhance its genetic diagnostics portfolio, and integrate Ambry’s expertise into its AI-driven precision medicine platform. Ambry Genetics is a US-based provider of hereditary and genetic testing services, including diagnostics for inherited conditions such as thrombophilia, cardiology, neurology, and rare diseases.

Regional Insights

North America was the largest region in the thrombophilia market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Thrombophilia Market?

The thrombophilia market consists of sales of rivaroxaban, apixaban, and thrombolytics. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Thrombophilia Market Report 2026?

The thrombophilia market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the thrombophilia industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Thrombophilia Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $19.6 billion
Revenue Forecast In 2035 $26.5 billion
Growth Rate CAGR of 7.8% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type, Drugs, Route Of Administration, End-Users
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Pfizer Inc., F. Hoffmann-La Roche Limited, Fresenius Kabi AG, Hikma Pharmaceuticals PLC., Novartis AG, Shenzhen Hepalink Pharmaceutical Group Co. Limited, Teva Pharmaceutical Industries Limited, Sanofi SA, Boehringer Ingelheim GmbH, Instrumentation Labor
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Thrombophilia Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Thrombophilia Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Thrombophilia Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Thrombophilia Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystem

4.2. Major Trends

4.2.1 Personalized Anticoagulant Therapy

4.2.2 Increased Genetic Screening For Thrombophilia

4.2.3 Advanced Diagnostic Testing For Blood Clotting Disorders

4.2.4 Rise In Awareness Programs For Blood Disorders

4.2.5 Integration Of Telemedicine In Thrombophilia Management

5. Thrombophilia Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Homecare

5.3 Specialty Centers

5.4 Diagnostic Laboratories

5.5 Research Institutes

6. Thrombophilia Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Thrombophilia Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Thrombophilia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Thrombophilia Market Size, Comparisons And Growth Rate Analysis

7.3. Global Thrombophilia Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Thrombophilia Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Thrombophilia Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Thrombophilia Market Segmentation

9.1. Global Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Factor V Leiden, Prothrombin 20210, Antiphospholipid Syndrome, Other Type

9.2. Global Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Heparin, Warfarin, Other Drugs

9.3. Global Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Parenteral, Other Route Of Administration

9.4. Global Thrombophilia Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Homecare, Specialty Centers, Other End Users

9.5. Global Thrombophilia Market, Sub-Segmentation Of Factor V Leiden, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Genetic Testing, Anticoagulant Therapy

9.6. Global Thrombophilia Market, Sub-Segmentation Of Prothrombin 20210, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Genetic Testing, Anticoagulant Therapy

9.7. Global Thrombophilia Market, Sub-Segmentation Of Antiphospholipid Syndrome, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Antiphospholipid Antibody Testing, Anticoagulant Therapy

9.8. Global Thrombophilia Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Protein C Deficiency, Protein S Deficiency, Antithrombin III Deficiency

10. Thrombophilia Market Regional And Country Analysis

10.1. Global Thrombophilia Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Thrombophilia Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Thrombophilia Market

11.1. Asia-Pacific Thrombophilia Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Thrombophilia Market, Segmentation By Type, Segmentation By Drugs, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Thrombophilia Market

12.1. China Thrombophilia Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Thrombophilia Market, Segmentation By Type, Segmentation By Drugs, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Thrombophilia Market

13.1. India Thrombophilia Market, Segmentation By Type, Segmentation By Drugs, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Thrombophilia Market

14.1. Japan Thrombophilia Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Thrombophilia Market, Segmentation By Type, Segmentation By Drugs, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Thrombophilia Market

15.1. Australia Thrombophilia Market, Segmentation By Type, Segmentation By Drugs, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Thrombophilia Market

16.1. Indonesia Thrombophilia Market, Segmentation By Type, Segmentation By Drugs, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Thrombophilia Market

17.1. South Korea Thrombophilia Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Thrombophilia Market, Segmentation By Type, Segmentation By Drugs, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Thrombophilia Market

18.1. Taiwan Thrombophilia Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Thrombophilia Market, Segmentation By Type, Segmentation By Drugs, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Thrombophilia Market

19.1. South East Asia Thrombophilia Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Thrombophilia Market, Segmentation By Type, Segmentation By Drugs, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Thrombophilia Market

20.1. Western Europe Thrombophilia Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Thrombophilia Market, Segmentation By Type, Segmentation By Drugs, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Thrombophilia Market

21.1. UK Thrombophilia Market, Segmentation By Type, Segmentation By Drugs, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Thrombophilia Market

22.1. Germany Thrombophilia Market, Segmentation By Type, Segmentation By Drugs, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Thrombophilia Market

23.1. France Thrombophilia Market, Segmentation By Type, Segmentation By Drugs, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Thrombophilia Market

24.1. Italy Thrombophilia Market, Segmentation By Type, Segmentation By Drugs, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Thrombophilia Market

25.1. Spain Thrombophilia Market, Segmentation By Type, Segmentation By Drugs, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Thrombophilia Market

26.1. Eastern Europe Thrombophilia Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Thrombophilia Market, Segmentation By Type, Segmentation By Drugs, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Thrombophilia Market

27.1. Russia Thrombophilia Market, Segmentation By Type, Segmentation By Drugs, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Thrombophilia Market

28.1. North America Thrombophilia Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Thrombophilia Market, Segmentation By Type, Segmentation By Drugs, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Thrombophilia Market

29.1. USA Thrombophilia Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Thrombophilia Market, Segmentation By Type, Segmentation By Drugs, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Thrombophilia Market

30.1. Canada Thrombophilia Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Thrombophilia Market, Segmentation By Type, Segmentation By Drugs, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Thrombophilia Market

31.1. South America Thrombophilia Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Thrombophilia Market, Segmentation By Type, Segmentation By Drugs, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Thrombophilia Market

32.1. Brazil Thrombophilia Market, Segmentation By Type, Segmentation By Drugs, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Thrombophilia Market

33.1. Middle East Thrombophilia Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Thrombophilia Market, Segmentation By Type, Segmentation By Drugs, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Thrombophilia Market

34.1. Africa Thrombophilia Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Thrombophilia Market, Segmentation By Type, Segmentation By Drugs, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Thrombophilia Market Regulatory and Investment Landscape

36. Thrombophilia Market Competitive Landscape And Company Profiles

36.1. Thrombophilia Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Thrombophilia Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Thrombophilia Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. F. Hoffmann-La Roche Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Hikma Pharmaceuticals PLC. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

37. Thrombophilia Market Other Major And Innovative Companies

Shenzhen Hepalink Pharmaceutical Group Co. Limited, Teva Pharmaceutical Industries Limited, Sanofi SA, Boehringer Ingelheim GmbH, Instrumentation Laboratory SpA, Johnson & Johnson, Bristol-Myers Squibb, Roche, Abbott, C. H. Boehringer Sohn, Portola Pharmaceuticals, Daiichi Sankyo, Bayer Group, CSL Behring, Merck & Co Inc.

38. Global Thrombophilia Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Thrombophilia Market

40. Thrombophilia Market High Potential Countries, Segments and Strategies

40.1 Thrombophilia Market In 2030 - Countries Offering Most New Opportunities

40.2 Thrombophilia Market In 2030 - Segments Offering Most New Opportunities

40.3 Thrombophilia Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Thrombophilia Market, Overview Of Key Products - Product Examples
  • Table 2: Global Thrombophilia Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Thrombophilia Market, Supply Chain Analysis
  • Table 4: Global Thrombophilia Market, Major Raw Material Providers
  • Table 5: Global Thrombophilia Market, Major Resource Providers
  • Table 6: Global Thrombophilia Market, Major Manufacturers (Suppliers)
  • Table 7: Global Thrombophilia Market, Major Distributors And Channel Partners
  • Table 8: Global Thrombophilia Market, Key Technologies & Future Trends
  • Table 9: Global Thrombophilia Market, Major Trends
  • Table 10: Global Thrombophilia Market, Major End Users
  • Table 11: Global Thrombophilia Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Thrombophilia Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Thrombophilia Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Thrombophilia Market - TAM, US$ Billion, 2025
  • Table 15: Global Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Thrombophilia Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Thrombophilia Market, Sub-Segmentation Of Factor V Leiden, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Thrombophilia Market, Sub-Segmentation Of Prothrombin 20210, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Thrombophilia Market, Sub-Segmentation Of Antiphospholipid Syndrome, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Thrombophilia Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Thrombophilia Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Thrombophilia Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Global Thrombophilia Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 98: Global Thrombophilia Market - Company Scoring Matrix
  • Table 99: Pfizer Inc. Financial Performance
  • Table 100: F. Hoffmann-La Roche Limited Financial Performance
  • Table 101: Fresenius Kabi AG Financial Performance
  • Table 102: Hikma Pharmaceuticals PLC. Financial Performance
  • Table 103: Novartis AG Financial Performance
  • Table 104: Global Thrombophilia Market, Competitive Benchmarking (In USD Billions)
  • Table 105: Global Thrombophilia Market, Competitive Dashboard
  • Table 106: Global Thrombophilia Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 107: Global, Thrombophilia Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 108: Global, Thrombophilia Market Size Gain ($ Billion), Segmentation By Drugs, 2025 – 2030
  • Table 109: Global, Thrombophilia Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

List Of Figures

    Figure 1: Global Thrombophilia Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Thrombophilia Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Thrombophilia Market, Supply Chain Analysis
  • Figure 4: Global Thrombophilia Market, Major Raw Material Providers
  • Figure 5: Global Thrombophilia Market, Major Resource Providers
  • Figure 6: Global Thrombophilia Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Thrombophilia Market, Major Distributors And Channel Partners
  • Figure 8: Global Thrombophilia Market, Key Technologies & Future Trends
  • Figure 9: Global Thrombophilia Market, Major Trends
  • Figure 10: Global Thrombophilia Market, Major End Users
  • Figure 11: Global Thrombophilia Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Thrombophilia Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Thrombophilia Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Thrombophilia Market - TAM, US$ Billion, 2025
  • Figure 15: Global Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Thrombophilia Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Thrombophilia Market, Sub-Segmentation Of Factor V Leiden, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Thrombophilia Market, Sub-Segmentation Of Prothrombin 20210, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Thrombophilia Market, Sub-Segmentation Of Antiphospholipid Syndrome, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Thrombophilia Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Thrombophilia Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Thrombophilia Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Thrombophilia Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Thrombophilia Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Thrombophilia Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Global Thrombophilia Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 98: Global Thrombophilia Market - Company Scoring Matrix
  • Figure 99: Pfizer Inc. Financial Performance
  • Figure 100: F. Hoffmann-La Roche Limited Financial Performance
  • Figure 101: Fresenius Kabi AG Financial Performance
  • Figure 102: Hikma Pharmaceuticals PLC. Financial Performance
  • Figure 103: Novartis AG Financial Performance
  • Figure 104: Global Thrombophilia Market, Competitive Benchmarking (In USD Billions)
  • Figure 105: Global Thrombophilia Market, Competitive Dashboard
  • Figure 106: Global Thrombophilia Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 107: Global, Thrombophilia Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 108: Global, Thrombophilia Market Size Gain ($ Billion), Segmentation By Drugs, 2025 – 2030
  • Figure 109: Global, Thrombophilia Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Read More About A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Read More About A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Read More About A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Read More About A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Deep Vein Thrombosis Market Report 2026 - Global Outlook – By Drug Class (Anticoagulants, Inferior Vena Cava Filters, Other Drug Class), By Treatment (Surgery, Drugs, Other Treatments), By Mode Of Administration (Injecta...

Thrombectomy Devices Market Report 2026 - Global Outlook – By Product Type (Aspiration Thrombectomy Devices, Mechanical Thrombectomy Devices), By Application (Neurovascular Applications, Peripheral Vascular Applications,...

Acromegaly Market Report 2026 - Global Outlook – By Type (Ectopic Acromegaly, Acromegaly Due To Growth Hormone), By Diagnosis (GH And IGF-I Measurement, Growth Hormone Suppression Test, Imaging, Other Diagnosis), By Rout...

Hemophilia Market Report 2026 - Global Outlook – By Type (Hemophilia A, Hemophilia B, Hemophilia C, Other Types), By Treatment (Replacement Therapy, Hemostatic Agents, Desmopressin, Gene Therapy, Other Treatments), By En...

Myelodysplastic Syndrome Market Report 2026 - Global Outlook – By Type (Myelodysplastic Syndrome With Unilineage Dysplasia, Myelodysplastic Syndrome With Multilineage Dysplasia, Myelodysplastic Syndrome With Ring Siderob...

Thrombophilia Market Report 2026 - Global Outlook – By Type (Factor V Leiden, Prothrombin 20210, Antiphospholipid Syndrome, Other Type), By Drugs (Heparin, Warfarin, Other Drugs), By Route Of Administration (Oral, Parent...

Venous Thromboembolism Market Report 2026 - Global Outlook – By Type (Deep Vein Thrombosis, Pulmonary Embolism, Other Types), By Treatment (Anti-Clotting Medications,  Mechanical Devices, Thrombolytic Therapy, Other Trea...

Antithrombotic Drugs Market - By Type Of Product (Anticoagulant Drugs, Antiplatelet Drugs, Thrombolytic Drugs), By Application (Blood Clot And Thromboembolic Treatment, Hyperlipidemia Treatment, Prophylactic Treatment, O...

Frequently Asked Questions

The Thrombophilia market was valued at $18.18 billion in 2025, increased to $19.6 billion in 2026, and is projected to reach $26.5 billion by 2030. request a sample here

The global Thrombophilia market is expected to grow at a CAGR of 7.8% from 2026 to 2035 to reach $26.5 billion by 2035. request a sample here

Some Key Players in the Thrombophilia market Include, Pfizer Inc., F. Hoffmann-La Roche Limited, Fresenius Kabi AG, Hikma Pharmaceuticals PLC., Novartis AG, Shenzhen Hepalink Pharmaceutical Group Co. Limited, Teva Pharmaceutical Industries Limited, Sanofi SA, Boehringer Ingelheim GmbH, Instrumentation Laboratory SpA, Johnson & Johnson, Bristol-Myers Squibb, Roche, Abbott, C. H. Boehringer Sohn, Portola Pharmaceuticals, Daiichi Sankyo, Bayer Group, CSL Behring, Merck & Co Inc., Janssen Pharmaceuticals . request a sample here

Major trend in this market includes: Groundbreaking Technological Advances And Long-Acting Drugs On The Horizon. For further insights on this market. request a sample here

North America was the largest region in the thrombophilia market in 2025. The regions covered in the thrombophilia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Major companies operating in the Thrombophilia Market Report 2026 market are Major companies operating in the thrombophilia market are Pfizer Inc., F. Hoffmann-La Roche Limited, Fresenius Kabi AG, Hikma Pharmaceuticals PLC., Novartis AG, Shenzhen Hepal request a sample here.

North America was the largest region in the thrombophilia market in 2025. The regions covered in the thrombophilia market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us